Structure of the human myostatin precursor and determinants of growth factor latency

EMBO J. 2018 Feb 1;37(3):367-383. doi: 10.15252/embj.201797883. Epub 2018 Jan 12.

Abstract

Myostatin, a key regulator of muscle mass in vertebrates, is biosynthesised as a latent precursor in muscle and is activated by sequential proteolysis of the pro-domain. To investigate the molecular mechanism by which pro-myostatin remains latent, we have determined the structure of unprocessed pro-myostatin and analysed the properties of the protein in its different forms. Crystal structures and SAXS analyses show that pro-myostatin adopts an open, V-shaped structure with a domain-swapped arrangement. The pro-mature complex, after cleavage of the furin site, has significantly reduced activity compared with the mature growth factor and persists as a stable complex that is resistant to the natural antagonist follistatin. The latency appears to be conferred by a number of distinct features that collectively stabilise the interaction of the pro-domains with the mature growth factor, enabling a regulated stepwise activation process, distinct from the prototypical pro-TGF-β1. These results provide a basis for understanding the effect of missense mutations in pro-myostatin and pave the way for the design of novel myostatin inhibitors.

Keywords: GDF8; TGF‐β superfamily; latency; myostatin; pro‐domain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Crystallography, X-Ray
  • Enzyme Activation / physiology
  • Follistatin / pharmacology
  • HEK293 Cells
  • Humans
  • Muscle, Skeletal / metabolism*
  • Myostatin / antagonists & inhibitors
  • Myostatin / metabolism*
  • Polymorphism, Genetic
  • Protein Precursors / metabolism*
  • Protein Structure, Secondary
  • Proteolysis
  • Transforming Growth Factor beta / metabolism

Substances

  • Follistatin
  • MSTN protein, human
  • Myostatin
  • Protein Precursors
  • Transforming Growth Factor beta